Roche Puts Future Germany Investment Decisions on Hold
Roche’s Germany chief said the company has put all future investment decisions in Germany on hold for the time being, citing healthcare cost-cutting policies.
Roche is reviewing all planned investments in Germany in response to healthcare cost-cutting policies, the drugmaker’s Germany chief told Welt in an interview published on Monday. “We have put all future investment decisions in Germany on hold for the time being,” the executive said.